COVID-19 rapid guideline: interstitial lung disease– guidance (NG177)

Guidance aims to maximise the safety of adults with interstitial lung disease, including idiopathic pulmonary fibrosis and pulmonary sarcoidosis, during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.


National Institute for Health and Care Excellence